Get the Stockscreener App
70.23
5.40%
3.60
Solventum Corp stock is traded at $70.23, with a volume of 1.82M.
It is up +5.40% in the last 24 hours and up +2.41% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
See More
Previous Close:
$66.63
Open:
$67.96
24h Volume:
1.82M
Relative Volume:
1.60
Market Cap:
$11.70B
Revenue:
$8.26B
Net Income/Loss:
$66.00M
P/E Ratio:
190.74
EPS:
0.3682
Net Cash Flow:
$1.17B
1W Performance:
+3.86%
1M Performance:
+2.41%
6M Performance:
-3.04%
1Y Performance:
+8.33%
1-Day Range:
$66.91
$71.08
1-Week Range:
$64.89
$71.08
52-Week Range:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
70.23 | 11.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - Zacks Investment Research
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum beats first-quarter profit estimates on strong surgical product sales - marketscreener.com
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum to Participate in the 2025 BofA Securities Health Care Conference - GuruFocus
Solventum Q1 Adjusted Earnings Fall, Sales Rise; 2025 Outlook Reaffirmed - marketscreener.com
Solventum Corp Q1 2025 Earnings: EPS at $0.78, Revenue Hits $2.1 Billion - GuruFocus
Solventum Corporation Q1 Profit Decreases, But Beats Estimates - Nasdaq
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses - MSN
Solventum Earnings: What To Look For From SOLV - Yahoo Finance
7 Analysts Assess Solventum: What You Need To Know - Benzinga
Solventum Corporation (SOLV): Among Billionaire Seth Klarman’s Stock Picks with Huge Upside Potential - Insider Monkey
Solventum price target lowered to $80 from $84 at Piper Sandler - TipRanks
Hologic Adds Wayde McMillan to its Board of Directors - Medical Product Outsourcing
Here's What to Expect From Solventum’s Next Earnings Report - Nasdaq
Here's What To Expect From Solventum’s Next Earnings Report - Barchart.com
Solventum Corporation (SOLV): Among the Best New Stocks to Buy According to Billionaires - MSN
Solventum Corporation (SOLV): Among Billionaire Nelson Peltz’s Stock Picks with Highest Upside Potential - Insider Monkey
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 16% Return On Equity? - simplywall.st
Solventum Stock Price, Quotes and Forecasts - Benzinga
Grin to Launch Digital Care Ecosystem at AAO 2025, Integrate with Clarity by Solventum - Orthodontic Products
Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025 - StreetInsider
Thermo Fisher acquires Solventum’s PF business in $4.1bn deal - Financier Worldwide
Solventum Corporation (NYSE:SOLV): Is the Spin-Off a Blessing in Disguise? - MSN
Big name companies are coming to Eagan. Is the suburb’s success a model for others? - Star Tribune
Solventum (SOLV) Soars 8.8%: Is Further Upside Left in the Stock? - Nasdaq
Integer Holdings Corp. hires SVPs from Solventum and Brink’s - Medical Design & Outsourcing
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):